CJC-1295 (No DAC) 5mg

CJC-1295 No DAC 5mg — Research Overview

CJC-1295 No DAC 5mg is a growth hormone-releasing hormone (GHRH) analogue designed for research into GH pulsatility and tissue regeneration. In preclinical studies, it is commonly paired with Ipamorelin to investigate recovery, muscle preservation and regenerative biology pathways. This compound is supplied by ReGen-X exclusively for scientific and laboratory research.

Mechanism of Action (Research Context)
In controlled research environments, CJC-1295 No DAC has been shown to influence the following pathways:

• Pulsatile growth hormone release — studied for its selective stimulation of GH secretion in research models
• Tissue repair and regeneration — associated with regenerative signalling in musculoskeletal research
• Protein synthesis — investigated for its role in muscle recovery and preservation pathways
• Preclinical recovery models — explored for enhancement of experimental recovery after induced injury

Research Summary
CJC-1295 No DAC has been evaluated in laboratory and experimental models for its potential role in:

• GH-mediated tissue and muscle repair research
• Regenerative biology pathway investigation
• Recovery enhancement in preclinical models
• Muscle growth and metabolic signalling studies

Browse our full range of Physical Recovery & Regeneration research compounds.

Product Specifications

• Compound: CJC-1295 No DAC 5mg
• Quantity: 5mg
• Form: Lyophilised research peptide
• Included: 10ml bacteriostatic water (for laboratory reconstitution only)
• Storage: Refrigerated per laboratory standards

Important Research Use Notice
This product is sold strictly for laboratory and scientific research use only. It is not a medicine, not a supplement, and not approved for human or veterinary use. No medical, therapeutic, or health claims are made or implied.